Irbesartan and Hydrochlorothiazide (LUPIN LIMITED)
Welcome to the PulseAid listing for the Irbesartan and Hydrochlorothiazide drug offered from LUPIN LIMITED. This Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
| LABELER NAME / MANUFACTURER: | LUPIN LIMITED |
| NON-PROPRIETARY NAME: | Irbesartan and Hydrochlorothiazide |
| SUBSTANCE NAME: | HYDROCHLOROTHIAZIDE; IRBESARTAN |
| TYPE: | HUMAN PRESCRIPTION DRUG |
| PHARMA CLASS: | Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [Chemical/Ingredient],Angiotensin 2 Receptor Antagonists [MoA],Angiotensin 2 Receptor Blocker [EPC] |
| ROUTE: | ORAL |
| DOSAGE FORM: | TABLET, FILM COATED |
| MARKETING CATEGORY NAME: | ANDA |
| START MARKETING DATE: | 2013-04-04 |
| END MARKETING DATE: | 0000-00-00 |
Irbesartan and Hydrochlorothiazide HUMAN PRESCRIPTION DRUG Details:
| Item Description | Irbesartan and Hydrochlorothiazide from LUPIN LIMITED |
| LABELER NAME: | LUPIN LIMITED |
| DEA SCHEDULE: |
|
| ACTIVE STRENGTH: | 12.5; 150(mg/1; mg/1) |
| START MARKETING DATE: | 2013-04-04 |
| END MARKETING DATE: | 0000-00-00 |
| PRODUCT ID: | 57297-413_ac69bbca-81f4-4896-bb7e-df0a4428fe42 |
| PRODUCT NDC: | 57297-413 |
| APPLICATION NUMBER: | ANDA201524 |
Other HYDROCHLOROTHIAZIDE; IRBESARTAN Pharmaceutical Manufacturers / Labelers:
